Vaxart, Inc. Share-based Payment Arrangement, Amount Capitalized
Vaxart, Inc. (VXRT) reported Share-based Payment Arrangement, Amount Capitalized of $0 for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2017-09-01
- Vaxart, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2016-12-31 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2016-09-30 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2015-12-31 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2015-09-30 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for fiscal 2017 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for fiscal 2016 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for fiscal 2015 was $0.00.
- Vaxart, Inc. share-based payment arrangement, amount capitalized for fiscal 2014 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 10-K · filed 2017-09-01 | |||
| 2016-12-31 | $0.00 10-Q · filed 2017-05-08 | $0.00 10-Q · filed 2017-02-06 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-05-08 | |||
| 2016-06-30 | $0.00 10-K · filed 2017-09-01 | |||
| 2015-12-31 | $0.00 10-Q · filed 2017-05-08 | $0.00 10-Q · filed 2017-02-06 | $0.00 derived: sum of 3 quarters · filed 2017-05-08 | $0.00 derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-09-30 | $0.00 10-Q · filed 2017-05-08 | $0.00 derived: sum of 2 quarters · filed 2017-05-08 | $0.00 derived: sum of 3 quarters · filed 2017-05-08 | $0.00 derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $0.00 derived: sum of 2 quarters · filed 2016-09-13 | $0.00 derived: sum of 3 quarters · filed 2016-09-13 | $0.00 10-K · filed 2016-09-13 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-05-08 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | $0.00 derived: sum of 3 quarters · filed 2015-11-06 | $0.00 derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 derived: sum of 3 quarters · filed 2015-11-06 | $0.00 derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | $0.00 derived: sum of 2 quarters · filed 2015-09-11 | $0.00 derived: sum of 3 quarters · filed 2015-09-11 | $0.00 10-K · filed 2015-09-11 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-05-08 | $0.00 10-Q · filed 2015-05-08 | |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |